D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
about
Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisImmunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancerD2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans.Macroscopic lymphovascular invasion visualized on mammogram and magnetic resonance imaging: Initially misidentified as ductal carcinoma in situ but properly diagnosed by immunohistochemistry.Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer.Immunohistochemical detection improves the prognostic value of lymphatic and blood vessel invasion in primary ductal breast cancer.D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasionD2-40, Podoplanin, and CD31 as a Prognostic Predictor in Invasive Ductal Carcinomas of the BreastThe different role of intratumoral and peritumoral lymphangiogenesis in gastric cancer progression and prognosis.A Pilot Study of Ultrasound-Guided Cryoablation of Invasive Ductal Carcinomas up to 15 mm With MRI Follow-Up and Subsequent Surgical ResectionGene expression profile of lymphatic endothelial cells.The optimum marker for the detection of lymphatic vessels.Histolopathologic approach to direct the management of the axilla in early breast cancer patients.Objective assessment of lymphatic and blood vascular invasion in lymph node-negative breast carcinoma: findings from a large case series with long-term follow-up.Lymphatic endothelial cancerization in papillary thyroid carcinoma: hidden evidence of lymphatic invasion.
P2860
Q26744296-9E379113-2653-4AC2-99A3-5A8033ABD029Q33428339-46F38EC2-D8FC-4C16-B759-B88392BB7F44Q33522929-9224E961-2480-4744-81D1-1D9E73B43A11Q33606336-28871A04-9740-4620-9F1F-866C2CE2E9A9Q33638445-EA4C2619-BE09-4527-9729-94432D81F593Q34143330-A5DA368D-D199-471C-859D-F0DF8194A2F1Q34253835-F3545DC2-3EA6-4F82-86FB-018CD889E990Q34566770-1A51995E-B1CC-4A85-BC87-EB290411601BQ35142225-9FD8CE38-50C7-4ED3-8FC1-065632571724Q35682525-5696DFE9-FDE6-4CEF-BE59-8795F9F87055Q36812132-D1EB29AC-80F1-4502-9806-CFABB04C43BFQ37954393-BB3B58EC-3DCA-42CC-9EC1-872B82B9AD1CQ41542533-BA9FB325-60E3-410C-8D4D-F84CFFDC2393Q48875025-6B0DFBD4-51B2-4360-A6FC-771E24BEDB93Q50530893-BFC4FF56-401E-4FBB-BD76-ED91CEE8343AQ53602035-DDB4F54E-36DC-46F8-A913-64C9147EFCB1
P2860
D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@en
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@nl
type
label
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@en
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@nl
prefLabel
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@en
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@nl
P1433
P1476
D2-40 expression by breast myo ...... cinoma from in situ carcinoma.
@en
P2093
Joseph T Rabban
Yunn-Yi Chen
P304
P356
10.1016/J.HUMPATH.2007.06.018
P407
P577
2008-02-01T00:00:00Z